Caitong International Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Hold
0
– -$1 – 3044
2026
Q1
– Sell
-7
Closed -$68 – 2466
2025
Q4
$80 Buy
+7
New +$108 ﹤0.01% 1713

Other funds holding CDLX

Caitong International Asset Management's CDLX Position: Q2 2026 in Review

Caitong International Asset Management held its Cardlytics (CDLX) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Caitong International Asset Management first reported a position in CDLX in Q4 2025 and has held it in 1 quarter since. The position peaked at $80 in Q4 2025. 43 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Caitong International Asset Management held 0 shares of Cardlytics worth $0 as of Q2 2026.
  • Caitong International Asset Management left its Cardlytics share count unchanged in Q2 2026.
  • Cardlytics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #3044 holding.
  • Caitong International Asset Management first reported a position in Cardlytics in Q4 2025 and has held it in 1 quarter since.
  • Caitong International Asset Management's Cardlytics position peaked at $80 in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.